145 related articles for article (PubMed ID: 27147638)
1. Higher incidence of morbidity in women than men with non-functioning pituitary adenoma: a Swedish nationwide study.
Olsson DS; Bryngelsson IL; Ragnarsson O
Eur J Endocrinol; 2016 Jul; 175(1):55-61. PubMed ID: 27147638
[TBL] [Abstract][Full Text] [Related]
2. Comorbidities in patients with non-functioning pituitary adenoma: influence of long-term growth hormone replacement.
Hammarstrand C; Ragnarsson O; Bengtsson O; Bryngelsson IL; Johannsson G; Olsson DS
Eur J Endocrinol; 2018 Oct; 179(4):229-237. PubMed ID: 30299891
[TBL] [Abstract][Full Text] [Related]
3. Incidence of malignant tumours in patients with a non-functioning pituitary adenoma.
Olsson DS; Hammarstrand C; Bryngelsson IL; Nilsson AG; Andersson E; Johannsson G; Ragnarsson O
Endocr Relat Cancer; 2017 May; 24(5):227-235. PubMed ID: 28274953
[TBL] [Abstract][Full Text] [Related]
4. Excess Mortality in Women and Young Adults With Nonfunctioning Pituitary Adenoma: A Swedish Nationwide Study.
Olsson DS; Nilsson AG; Bryngelsson IL; Trimpou P; Johannsson G; Andersson E
J Clin Endocrinol Metab; 2015 Jul; 100(7):2651-8. PubMed ID: 25946030
[TBL] [Abstract][Full Text] [Related]
5. Time trends of mortality in patients with non-functioning pituitary adenoma: a Swedish nationwide study.
Olsson DS; Bryngelsson IL; Ragnarsson O
Pituitary; 2017 Apr; 20(2):218-224. PubMed ID: 27743172
[TBL] [Abstract][Full Text] [Related]
6. Excess mortality and morbidity in patients with craniopharyngioma, especially in patients with childhood onset: a population-based study in Sweden.
Olsson DS; Andersson E; Bryngelsson IL; Nilsson AG; Johannsson G
J Clin Endocrinol Metab; 2015 Feb; 100(2):467-74. PubMed ID: 25375987
[TBL] [Abstract][Full Text] [Related]
7. Incidence, mortality, and cardiovascular diseases in pituitary adenoma in Korea: a nationwide population-based study.
Oh JS; Kim HJ; Hann HJ; Kang TU; Kim DS; Kang MJ; Lee JY; Shim JJ; Lee MR; Ahn HS
Pituitary; 2021 Feb; 24(1):38-47. PubMed ID: 32949324
[TBL] [Abstract][Full Text] [Related]
8. The incidence rate of pituitary adenomas in western Sweden for the period 2001-2011.
Tjörnstrand A; Gunnarsson K; Evert M; Holmberg E; Ragnarsson O; Rosén T; Filipsson Nyström H
Eur J Endocrinol; 2014 Oct; 171(4):519-26. PubMed ID: 25084775
[TBL] [Abstract][Full Text] [Related]
9. Excess morbidity and mortality in patients with craniopharyngioma: a hospital-based retrospective cohort study.
Wijnen M; Olsson DS; van den Heuvel-Eibrink MM; Hammarstrand C; Janssen JAMJL; van der Lely AJ; Johannsson G; Neggers SJCMM
Eur J Endocrinol; 2018 Jan; 178(1):93-102. PubMed ID: 29046325
[TBL] [Abstract][Full Text] [Related]
10. Comorbidity and cardiovascular risk factors in adult GH deficiency following treatment for Cushing's disease or non-functioning pituitary adenomas during childhood.
Ragnarsson O; Höybye C; Jönsson PJ; Feldt-Rasmussen U; Johannsson G; Biller BM; Koltowska-Häggström M
Eur J Endocrinol; 2012 Apr; 166(4):593-600. PubMed ID: 22258111
[TBL] [Abstract][Full Text] [Related]
11. The epidemiology of pituitary adenomas in Iceland, 1955-2012: a nationwide population-based study.
Agustsson TT; Baldvinsdottir T; Jonasson JG; Olafsdottir E; Steinthorsdottir V; Sigurdsson G; Thorsson AV; Carroll PV; Korbonits M; Benediktsson R
Eur J Endocrinol; 2015 Nov; 173(5):655-64. PubMed ID: 26423473
[TBL] [Abstract][Full Text] [Related]
12. Pituitary adenomas in northern Sweden: a study on therapy choices and the risk of second primary tumours.
Norberg L; Johansson R; Rasmuson T
Clin Endocrinol (Oxf); 2008 May; 68(5):780-5. PubMed ID: 17980004
[TBL] [Abstract][Full Text] [Related]
13. Cerebrovascular events, secondary intracranial tumors, and mortality after radiotherapy for nonfunctioning pituitary adenomas: a subanalysis from the Dutch National Registry of Growth Hormone Treatment in Adults.
van Varsseveld NC; van Bunderen CC; Ubachs DH; Franken AA; Koppeschaar HP; van der Lely AJ; Drent ML
J Clin Endocrinol Metab; 2015 Mar; 100(3):1104-12. PubMed ID: 25574793
[TBL] [Abstract][Full Text] [Related]
14. New Neoplasm During GH Replacement in Adults With Pituitary Deficiency Following Malignancy: A KIMS Analysis.
Krzyzanowska-Mittermayer K; Mattsson AF; Maiter D; Feldt-Rasmussen U; Camacho-Hübner C; Luger A; Abs R
J Clin Endocrinol Metab; 2018 Feb; 103(2):523-531. PubMed ID: 29228199
[TBL] [Abstract][Full Text] [Related]
15. Italian cancer figures, report 2013: Multiple tumours.
AIRTUM Working Group
Epidemiol Prev; 2013; 37(4-5 Suppl 1):1-152. PubMed ID: 24259384
[TBL] [Abstract][Full Text] [Related]
16. National incidence and prevalence of TSH-secreting pituitary adenomas in Sweden.
Ónnestam L; Berinder K; Burman P; Dahlqvist P; Engström BE; Wahlberg J; Nyström HF
J Clin Endocrinol Metab; 2013 Feb; 98(2):626-35. PubMed ID: 23295463
[TBL] [Abstract][Full Text] [Related]
17. Relationship of each anterior pituitary hormone deficiency to the size of non-functioning pituitary adenoma in the hospitalized patients.
Mukai K; Kitamura T; Tamada D; Murata M; Otsuki M; Shimomura I
Endocr J; 2016 Nov; 63(11):965-976. PubMed ID: 27534814
[TBL] [Abstract][Full Text] [Related]
18. Pituitary adenomas in Sweden between 1958 and 1991: incidence, survival, and mortality.
Nilsson B; Gustavasson-Kadaka E; Bengtsson BA; Jonsson B
J Clin Endocrinol Metab; 2000 Apr; 85(4):1420-5. PubMed ID: 10770176
[TBL] [Abstract][Full Text] [Related]
19. Risk factors, treatment and prognosis in men and women with heart failure with and without diabetes.
Johansson I; Dahlström U; Edner M; Näsman P; Rydén L; Norhammar A
Heart; 2015 Jul; 101(14):1139-48. PubMed ID: 26034118
[TBL] [Abstract][Full Text] [Related]
20. Diabetes patients requiring glucose-lowering therapy and nondiabetics with a prior myocardial infarction carry the same cardiovascular risk: a population study of 3.3 million people.
Schramm TK; Gislason GH; Køber L; Rasmussen S; Rasmussen JN; Abildstrøm SZ; Hansen ML; Folke F; Buch P; Madsen M; Vaag A; Torp-Pedersen C
Circulation; 2008 Apr; 117(15):1945-54. PubMed ID: 18378618
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
